Skip to main content
. 2018 Aug 22;18(4):3699–3710. doi: 10.3892/mmr.2018.9419

Figure 6.

Figure 6.

Alo blocks the Ras/Raf1/Erk1/2 signaling pathway in breast cancer cells. Western blotting was performed to analyze the expression of Ras, p-Raf1, Raf1, p-Erk1/2 and Erk1/2 following Alo (0.1, 0.2 and 0.4 mM) treatment for 24 h. Then the band intensity was quantified by ImageJ software. The results were expressed as the mean ± standard deviation of three independent experiments. *P<0.05 and **P<0.01 vs. non-Alo treated group (0 mM Alo). Alo, Aloperine; Raf, Raf proto-oncogene, serine/threonine kinase; Erk1/2, extracellular signal-regulated kinase 1/2; p-, phosphorylated.